| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/13/2004 | WO2003049762A3 Immunisation against chlamydia trachomatis |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003040293A3 Genes coding for stress resistance and tolerance proteins |
| 05/13/2004 | WO2003038051A9 Method of inducing apoptosis in hyperproliferative cells |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003029471A8 Muteins of apolipoprotein d |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003005636A8 Secure header information for multi-content e-mail |
| 05/13/2004 | WO2002097038A9 Chemokine beta-1 fusion proteins |
| 05/13/2004 | WO2002089731A9 Agents for treatment of hcv and methods of use |
| 05/13/2004 | WO2002062836A9 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 05/13/2004 | WO2002061041A9 Solubility reporter gene constructs |
| 05/13/2004 | WO2002057301A3 Gene silencing suppressor |
| 05/13/2004 | WO2002028873A8 Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon |
| 05/13/2004 | WO2002012273A9 Herbicide target genes and methods |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | WO2000069885A8 Secreted proteins and uses thereof |
| 05/13/2004 | US20040093646 Production of lysosomal enzymes in plants by transient expression |
| 05/13/2004 | US20040093644 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 05/13/2004 | US20040093643 Preparing transgenic plants for use as bioreactors in generation of therapeutic proteins; pharmacogenetics |
| 05/13/2004 | US20040093637 Hybrid Bacillus thuringiensis delta-endotoxins with novel broad-spectrum insecticidal activity |
| 05/13/2004 | US20040093633 Comprises nucleotide sequences coding resistance to powdery mildew-8 gene for transformation and generation of plants tolerant of fungal diseases |
| 05/13/2004 | US20040093630 Zebrafish huc promoter capable of directing neuron-specific expression of structural genes, transgenic animal having huc promoter and its generation, and method for screening neuronal mutant animals using the transgenic animal |
| 05/13/2004 | US20040093629 Comprises n-glycosylated polypeptide for inhibiting intestinal cholesterol absorption and treating cardiovascular disorders |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040093625 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines |
| 05/13/2004 | US20040093623 Non-human animal disease models |
| 05/13/2004 | US20040093165 Estrogen receptor ligands |
| 05/13/2004 | US20040093164 Computer system and methods for producing morphogen analogs of human TDF-1 |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092729 Oligonucleotide sequences coding genetic suppressor elements resistant to antitumor agents; multidrug resistance in cancer cells |
| 05/13/2004 | US20040092724 Transmembrane mucopolysaccharide for treatment and diagnosis of cell proliferative disorders and cancer; antitumor agents |
| 05/13/2004 | US20040092720 Prevent binding to immunoglobulins; genetic engineering; leukemia, antiproliferative agents, rheumatic diseases |
| 05/13/2004 | US20040092717 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 05/13/2004 | US20040092716 Comprises adrenal-4 binding protein for identifying modulator for treatment of endrocrine disorders |
| 05/13/2004 | US20040092715 Intracellular signaling molecules |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092713 Comprises membrane proteins for diagnosis, prevention and treatment of diabetes, tumor, sexual and nervous system disorders |
| 05/13/2004 | US20040092711 Hybrid expression of neisserial proteins |
| 05/13/2004 | US20040092709 Peptide mimics of the cytokine receptor common gamma chain and methods and compositions for making and using the same |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092469 Androgen-regulated PMEPA1 gene and polypeptides |
| 05/13/2004 | US20040092450 Polypeptide that has mitogenic activity; treating fibroproliferative disorders |
| 05/13/2004 | US20040092448 Adding to multipotent neural stem cells; treating neurodegenerative disorders and brain injuries |
| 05/13/2004 | US20040092447 Uses of kappa-conotoxin PVIIA |
| 05/13/2004 | US20040092446 HA-1 epitopes and uses thereof |
| 05/13/2004 | US20040092444 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 05/13/2004 | US20040092443 Long-acting exendins and exendin agonists |
| 05/13/2004 | US20040092442 Inactivation resistant factor VIII |
| 05/13/2004 | US20040092441 Tyrosine kinase modulators |
| 05/13/2004 | US20040092439 Migraine and vasodilation treatment |
| 05/13/2004 | US20040092437 Using genetically engineered mammalian plasma protein to prevent and treat transplant rejection, graft-versus-host and autoimmune diseases; side effect reduction and tumor therapy |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092432 Cognition activators; central nervous system disorders; administering isolated nucleic acid |
| 05/13/2004 | US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease |
| 05/13/2004 | US20040092019 Particle-mediated transformation of animal tissue cells |
| 05/13/2004 | US20040092017 Binary viral expression system in plants |
| 05/13/2004 | US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector |
| 05/13/2004 | US20040092009 Codon optimized synthetic plasmids |
| 05/13/2004 | US20040092008 Recombinant AAV vectors for gene therapy of hemophilia A |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091991 Simultaneous modulation of multiple genes |
| 05/13/2004 | US20040091990 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 05/13/2004 | US20040091972 Membrane protein for diagnosis, prevention and treatment cell proliferative disorders |
| 05/13/2004 | US20040091971 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine |
| 05/13/2004 | US20040091970 Mammalian cytokines; related reagents and methods |
| 05/13/2004 | US20040091969 Novel compounds |
| 05/13/2004 | US20040091964 Modified proteins, isolated novel peptides,and uses thereof |
| 05/13/2004 | US20040091961 Enhanced variants of erythropoietin and methods of use |
| 05/13/2004 | US20040091960 Novel physiologically active peptides and use thereof |
| 05/13/2004 | US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer |
| 05/13/2004 | US20040091958 Expression vector coding glyceraldehyde-3-phosphate dehydrogenase for transformation of phaffa and biosyntnhesis of astaxanthin |
| 05/13/2004 | US20040091956 Biosynthesis using blocked amino acids; deblocking; separation; purification; immunomoderators; multiple sclerosis |
| 05/13/2004 | US20040091955 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/13/2004 | US20040091946 Methods of screening compositions for G protein -coupled receptor desensitization inhibitory activity |
| 05/13/2004 | US20040091945 Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091938 Comprises mutant maackia amurensis hemagglutinin for use in analyzing cell surface sugar chains and diagnosing kidney disorders |
| 05/13/2004 | US20040091935 Comprises nucleotide sequences coding mycoplasmal protein associated with autoimmune and skin disorders for treating and preventing scleroderma |
| 05/13/2004 | US20040091934 Peptides and their use in assays for cardiovascular disease |
| 05/13/2004 | US20040091931 Comprises fusion protein for identifying ligands and/or treatment which modulate transmembrane binding; diagnosis and treatment of asthma, chronic obstructive pulmonary disease, cystic fibrosis, sinusitis, and nervous system disorders |
| 05/13/2004 | US20040091929 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
| 05/13/2004 | US20040091928 Comprises nucleotide sequences coding transmembrane receptors for identification of modulator for diagnosis, prevention and treatment of psychological and schizophrenic disorders |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091908 Useful in drug design methods to identify agents that may interact with active sites |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091904 Methods for identifying compounds that bind to a target |
| 05/13/2004 | US20040091901 Of given amino acid sequence; use in diagnosis and treatment of enzootic pneumonia in swine; kits |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091884 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091863 For inflammation/multiple sclerosis/arthritis/skin/respiratory disorders/cancer/tumors/reperfusion injuries; comprises cell-free in vitro translation system; solid phase synthesis |
| 05/13/2004 | US20040091861 Novel polypeptide-human shc protein 43 and polynucleotide encoding it |
| 05/13/2004 | US20040091856 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| 05/13/2004 | US20040091855 For producing drugs by detecting in vitro complex formations |
| 05/13/2004 | US20040091853 Features a chimeric protein containing beta-lactamase and Vpr/Vpx region; for lentivirus/human immunodeficiency virus (HIV) |
| 05/13/2004 | US20040091852 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |